Skip to main content

Want a detailed portfolio tracker?

Pharvaris (PHVS) P/E (2021 - 2026)

Pharvaris (PHVS) P/E from Feb 5, 2021 to Jul 21, 2026. The TTM Pharvaris (PHVS) P/E is -10.68. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Pharvaris (PHVS)

YearP/EChange
2026-10.68+32.40%
2025-8.06+12.39%
2024-7.17-13.56%
2023-8.30+19.91%
2022-6.92-27.40%
2021-9.53N/A

Comparison Pharvaris (PHVS) P/E with competitors

Pharvaris (PHVS) P/E is -10.68.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.02%
NBYStablecoin Development Corp0.00-100.04%
ENLVEnlivex Ltd0.07-100.70%
FGENFibroGen Inc0.24-102.25%
CHRSCoherus Biosciences Inc0.85-107.95%
FBIOFortress Biotech Inc0.95-108.89%
ORMPOramed Pharmaceuticals Inc1.50-114.08%
AGENAgenus Inc3.01-128.19%
INVAInnoviva Inc3.15-129.54%
VXRTVaxart Inc3.55-133.25%
CRMDCorMedix Inc3.63-133.99%
CVACCureVac N.V.4.45-141.64%
GLPGGalapagos NV4.86-145.51%
SRPTSarepta Therapeutics Inc4.88-145.73%
ABEOAbeona Therapeutics Inc5.39-150.46%
ABUSArbutus Biopharma Corp5.60-152.41%
ZVRAZevra Therapeutics Inc5.89-155.14%
SPROSpero Therapeutics Inc6.23-158.34%
CGENCompugen Ltd6.31-159.14%
RIGLRigel Pharmaceuticals6.87-164.37%
SLXNSilexion Therapeutics Corp7.30-168.34%
OMEROmeros Corporation9.26-186.72%
AUPHAurinia Pharmaceuticals Inc9.58-189.78%
PLXProtalix BioTherapeutics Inc10.89-202.01%
ACADAcadia Pharmaceuticals Inc11.73-209.85%
TBPHTheravance Biopharma Inc12.26-214.85%
ADMAAdma Biologics Inc12.42-216.31%
HRMYHarmony Biosciences Holdings Inc13.82-229.45%
SABSSAB Biotherapeutics Inc14.14-232.41%
NAGENiagen Bioscience Inc14.82-238.79%
INCYIncyte Corp15.82-248.20%
REGNRegeneron Pharmaceuticals Inc15.86-248.52%
PBYIPuma Biotechnology Inc17.32-262.19%
CPRXCatalyst Pharmaceuticals Inc17.44-263.34%
EXELExelixis Inc17.54-264.27%
TGTXTG Therapeutics Inc18.97-277.64%
MDXGMimedx Group Inc20.55-292.50%
XOMAXOMA Royalty Corp22.87-314.26%
ARGXArgen X SE24.30-327.59%
CTMXCytomX Therapeutics Inc24.82-332.49%
XOMAOXOMA Royalty Corp25.34-337.40%
HALOHalozyme Therapeutics Inc25.62-340.01%
XOMAPXOMA Royalty Corp25.67-340.44%
VRTXVertex Pharmaceuticals Inc27.99-362.22%
RPRXRoyalty Pharma plc - Class A28.69-368.71%
SLNOSoleno Therapeutics Inc29.02-371.78%
ASNDAscendis Pharma A/S30.09-381.80%
LGNDLigand Pharmaceuticals Inc - Class B37.91-455.11%
APLSApellis Pharmaceuticals Inc39.02-465.50%
BMRNBiomarin Pharmaceutical Inc42.21-495.39%
KRYSKrystal Biotech Inc45.34-524.72%
ONCBeiGene Ltd69.54-751.36%
TECHBio-Techne Corp101.96-1055.01%
VCELVericel Corp109.92-1129.60%
ALNYAlnylam Pharmaceuticals Inc117.96-1204.94%
GMABGenmab140.29-1414.06%
TLXTelix Pharmaceuticals Ltd162.15-1618.84%
CORTCorcept Therapeutics Inc212.86-2093.77%